# Senior Manager RWE Biostats — Bristol Myers Squibb

- Location: United States
- Posted pay: $189k–$229k/yr
- Posted: Nov 17, 2026
- Status: open (checked Nov 22, 2026)
- Apply (employer's site): https://bristolmyerssquibb.wd5.myworkdayjobs.com/BMS/job/Princeton---NJ---US/EG-130---Clinical-Development---Biostatistics_R1606428
- Employer record: https://visajobs.io/company/bristol-myers-squibb.md

## Sponsorship history
- Tier: Employer history only
- With this exact title: 0

## Description
At Bristol Myers Squibb, our employees often ask, “Who are you working for?”—a question that fuels collaboration, accountability, and urgency in our work. Our purpose-driven culture inspires us to discover, develop, and deliver innovative medicines to prevail over serious diseases. We offer uniquely interesting and meaningful work, opportunities for growth, and a supportive environment that values inclusion, wellbeing, flexibility, and comprehensive benefits. This is work that transforms the lives of patients, and the careers of those who do it.
Position Summary
You will join a cutting-edge Drug Development Data Science and Advanced Analytics (DSAA) team to advance the global drug development process. We are looking for a candidate with strong computational, statistical, and data engineering capabilities and a demonstrated track record of working with real-world data (RWD) , including electronic health records (EHR), claims data, patient registries, and other real-world evidence (RWE) sources, to generate actionable insights that inform clinical trial design and treatment evaluation . This role requires deep expertise across the full RWD analytics lifecycle: from data sourcing, engineering, and quality assessment, through to statistical analysis, summary extraction, and AI/ML predictive modeling.
In addition to the RWD focus, this role contributes to broader data science objectives spanning genomics, proteomics, imaging, flow cytometry, and other biomarker data types generated from clinical trials. As a hands-on individual contributor, you will drive exploratory and confirmatory analyses that support drug development decisions across early-to-late phase programs, collaborating closely with Biostatistics leads, Translational and Clinical Scientists, and cross-functional partners. We are looking for a hands-on, state-of-the-art practitioner.
What You'll Do
Real-World Data Science (Deep Expertise)
Data Engineering & Infrastructure Design, build, and maintain scalable data pipelines for ingesting, harmonizing, and transforming large-scale RWD sources, including EHR, medical/pharmacy claims, patient registries, lab data, and linked multi-source datasets
Develop and implement robust data quality frameworks to assess completeness, consistency, accuracy, and fitness-for-purpose of RWD sources for specific analytical questions
Apply data standardization and interoperability best practices (e.g., OMOP CDM, FHIR, SNOMED, ICD, RxNorm) to enable cross-source analyses and longitudinal patient cohort construction
Build reproducible, well-documented, version-controlled codebases using Python, R, SQL, and cloud platforms (e.g., AWS, Azure, Databricks)
Data Processing, Curation & Cohort Development Define and implement rigorous patient identification, cohort selection, and exposure/outcome definition algorithms from complex, noisy real-world datasets
Develop and apply algorithms for data cleaning, deduplication, record linkage, and handling of missing, irregular, or censored data in RWD contexts
Extract clinically meaningful features and summary measures from unstructured and structured RWD, including NLP-based extraction from clinical notes and free-text fields
Construct longitudinal patient-level datasets that accurately capture treatment patterns, disease progression, healthcare utilization, and outcomes
Oncology Real-World Data (Emphasis Area)
Work with oncology-specific RWD sources including EHR platforms (e.g., Flatiron Health, Tempus), tumor registries (e.g., SEER, NCDB), and molecularly-linked datasets integrating clinical outcomes with genomic profiling (e.g., NGS, TMB, MSI, PD-L1)
Construct and validate oncology patient cohorts, including LOT sequences, biomarker-defined subgroups (e.g., PD-L1, MSI, TMB, EGFR, KRAS), and longitudinal treatment histories from fragmented, incomplete real-world records
Apply methods appropriate for oncology RWD outcomes (rwOS, rwPFS, TTNT, rwRR) while addressing oncology-specific analytical challenges, including immortal time bias, informative censoring, death ascertainment, and treatment switching
Support comparative effectiveness and external control arm (ECA) analyses for oncology programs, with awareness of FDA/EMA guidance on RWE use in oncology regulatory submissions
Bring familiarity with immuno-oncology treatment landscapes and associated analytical complexities, including delayed response patterns and immune-related adverse events (irAEs)
Statistical Analysis & Real-World Evidence Generation Apply advanced statistical and epidemiological methods appropriate for RWD, including propensity score methods (matching, weighting, stratification), instrumental variable analysis, difference-in-differences, interrupted time series, and other causal inference frameworks
Perform robust characterization of patient populations, treatment patterns, comparative effectiveness, and outcomes from RWD to support clinical development strategy
Develop and apply survival analysis and time-to-event models to evaluate treatment effects and disease trajectories in real-world cohorts
Apply longitudinal and mixed-effects modeling approaches to repeated-measures RWD with appropriate handling of informative censoring and irregular observation times
Contribute to the design and execution of RWE studies, observational analyses, and external control arm (ECA) analyses to inform regulatory submissions and clinical decisions
AI/ML Predictive Modeling & Insight Generation Develop, validate, and deploy AI/ML predictive models using RWD to support patient stratification, treatment response prediction, disease progression modeling, and identification of novel prognostic and predictive factors
Apply classical machine learning (e.g., regularized regression, gradient boosting, random forests) and deep learning approaches (e.g., recurrent/transformer architectures for longitudinal EHR data) with rigorous model evaluation and explainability practices
Leverage NLP and large language model (LLM)-based 

> History, not a promise: past H-1B filings do not mean an employer will sponsor you or a given role. Data: U.S. DOL OFLC LCA disclosure (FY2024–FY2026 for role counts, certified LCAs) and the USCIS H-1B Employer Data Hub. Not legal advice. Methodology: https://visajobs.io/methodology
